Afrezza, a New Inhaled Insulin, Is Approved by F.D.A. by ANDREW POLLACK

By ANDREW POLLACK

The approval is a huge milestone for MannKind Corporation but concerns linger about the drug’s potential effect on patients’ lungs.

Published: June 28, 2014 at 4:00AM

from NYT Business Day http://ift.tt/1mEDLvI

from WordPress http://ift.tt/1qS4SWV

via Hadi Aboukhater